Manulife (Manufacturers Life Insurance)’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $130M | Buy |
539,037
+3,975
| +0.7% | +$871K | 0.1% | 194 |
|
|
2026
Q1 | $101M | Sell |
535,062
-12,681
| -2% | -$2.22M | 0.09% | 217 |
|
|
2025
Q4 | $93.1M | Buy |
547,743
+31,432
| +6% | +$4.82M | 0.08% | 239 |
|
|
2025
Q3 | $68M | Sell |
516,311
-31,626
| -6% | -$3.79M | 0.06% | 299 |
|
|
2025
Q2 | $58.1M | Buy |
547,937
+32,530
| +6% | +$3.53M | 0.05% | 312 |
|
|
2025
Q1 | $64M | Buy |
515,407
+161,940
| +46% | +$21.1M | 0.06% | 285 |
|
|
2024
Q4 | $43.5M | Buy |
353,467
+5,715
| +2% | +$674K | 0.04% | 395 |
|
|
2024
Q3 | $38.7M | Sell |
347,752
-3,019
| -0.9% | -$331K | 0.03% | 434 |
|
|
2024
Q2 | $37.4M | Sell |
350,771
-2,173
| -0.6% | -$239K | 0.04% | 418 |
|
|
2024
Q1 | $42.5M | Buy |
352,944
+73,516
| +26% | +$9M | 0.04% | 380 |
|
|
2023
Q4 | $34.4M | Buy |
279,428
+142,606
| +104% | +$17.8M | 0.02% | 466 |
|
|
2023
Q3 | $17.7M | Buy |
136,822
+6,553
| +5% | +$873K | 0.01% | 624 |
|
|
2023
Q2 | $16.1M | Sell |
130,269
-1,117
| -0.9% | -$150K | 0.01% | 649 |
|
|
2023
Q1 | $19.2M | Sell |
131,386
-826
| -0.6% | -$122K | 0.01% | 620 |
|
|
2022
Q4 | $21.1M | Buy |
132,212
+114
| +0.1% | +$16.7K | 0.01% | 574 |
|
|
2022
Q3 | $17.6M | Buy |
132,098
+40,005
| +43% | +$6.08M | 0.01% | 619 |
|
|
2022
Q2 | $14.4M | Sell |
92,093
-37,142
| -29% | -$5.72M | 0.01% | 700 |
|
|
2022
Q1 | $20.2M | Buy |
129,235
+60,938
| +89% | +$8.84M | 0.01% | 664 |
|
|
2021
Q4 | $8.7M | Sell |
68,297
-870
| -1% | -$114K | 0.01% | 1012 |
|
|
2021
Q3 | $9.01M | Buy |
69,167
+4,592
| +7% | +$694K | 0.01% | 976 |
|
|
2021
Q2 | $11.5M | Buy |
64,575
+2,536
| +4% | +$439K | 0.01% | 904 |
|
|
2021
Q1 | $10.2M | Sell |
62,039
-3,838
| -6% | -$632K | 0.01% | 945 |
|
|
2020
Q4 | $10.9M | Sell |
65,877
-5,659
| -8% | -$843K | 0.01% | 855 |
|
|
2020
Q3 | $10.2M | Buy |
+71,536
| New | +$8.87M | 0.01% | 793 |
|
|
2018
Q3 | – | Sell |
-335
| Closed | -$58K | – | 3434 |
|
|
2018
Q2 | $58K | Sell |
335
-42
| -11% | -$6.87K | ﹤0.01% | 3532 |
|
|
2018
Q1 | $57K | Sell |
377
-6
| -2% | -$880 | ﹤0.01% | 3526 |
|
|
2017
Q4 | $52K | Sell |
383
-1
| -0.3% | -$139 | ﹤0.01% | 3538 |
|
|
2017
Q3 | $57K | Buy |
384
+27
| +8% | +$4.08K | ﹤0.01% | 3457 |
|
|
2017
Q2 | $55K | Buy |
357
+52
| +17% | +$7.95K | ﹤0.01% | 3463 |
|
|
2017
Q1 | $44K | Sell |
305
-152
| -33% | -$19.8K | ﹤0.01% | 3383 |
|
|
2016
Q4 | $50K | Sell |
457
-62
| -12% | -$6.91K | ﹤0.01% | 3422 |
|
|
2016
Q3 | $63K | Buy |
519
+6
| +1% | +$809 | ﹤0.01% | 3349 |
|
|
2016
Q2 | $72K | Buy |
513
+99
| +24% | +$14.6K | ﹤0.01% | 3291 |
|
|
2016
Q1 | $51K | Buy |
414
+57
| +16% | +$7.09K | ﹤0.01% | 3278 |
|
|
2015
Q4 | $50K | Hold |
357
| – | – | ﹤0.01% | 3270 |
|
|
2015
Q3 | $47K | Sell |
357
-43
| -11% | -$7.4K | ﹤0.01% | 3329 |
|
|
2015
Q2 | $70K | Hold |
400
| – | – | ﹤0.01% | 3329 |
|
|
2015
Q1 | $69K | Hold |
400
| – | – | ﹤0.01% | 3271 |
|
|
2014
Q4 | $65K | Buy |
+400
| New | +$66.4K | ﹤0.01% | 3180 |
|
|
2013
Q4 | – | Sell |
-2,214
| Closed | -$204K | – | 3844 |
|
|
2013
Q3 | $204K | Buy |
+2,214
| New | +$179K | ﹤0.01% | 2640 |
|
Other funds holding JAZZ
Manulife (Manufacturers Life Insurance)'s JAZZ Position: Q2 2026 in Review
Manulife (Manufacturers Life Insurance) increased its Jazz Pharmaceuticals (JAZZ) stake by 0.74% in Q2 2026, buying an estimated $871K and bringing the position to 539,037 shares worth $130M. The position accounts for 0.1% of the portfolio, ranked #194.
Manulife (Manufacturers Life Insurance) first reported a position in JAZZ in Q3 2013 and has held it in 40 quarters since. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Manulife (Manufacturers Life Insurance) held 539,037 shares of Jazz Pharmaceuticals worth $130M as of Q2 2026.
- Manulife (Manufacturers Life Insurance) bought 3,975 Jazz Pharmaceuticals shares in Q2 2026, an estimated $871K.
- Jazz Pharmaceuticals made up 0.1% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #194 holding.
- Manulife (Manufacturers Life Insurance) first reported a position in Jazz Pharmaceuticals in Q3 2013 and has held it in 40 quarters since.
- 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.